Rituximab treatment for posttransplantation lymphoproliferative disorder after small bowel transplantation.
Nishida
S
S
Department of Surgery, University of Miami School of Medicine, Miami, Florida 33136, USA.
Kato
T
T
Burney
T
T
Levi
D
D
Nery
J
J
Madariaga
J
J
Mittal
N
N
Weppler
D
D
Ruiz
P
P
Tzakis
A
A
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007223:Infant; D007421:Intestine, Small / Q000637:transplantation*; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy*; D012189:Retrospective Studies; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab